4//SEC Filing
MILLIGAN JOHN F 4
Accession 0001567619-21-010748
CIK 0001650648other
Filed
May 18, 8:00 PM ET
Accepted
May 19, 8:33 PM ET
Size
8.0 KB
Accession
0001567619-21-010748
Insider Transaction Report
Form 4
MILLIGAN JOHN F
Director
Transactions
- Award
Stock Option (Right to Buy)
2021-05-17+22,500→ 22,500 totalExercise: $26.89Exp: 2031-05-16→ Common Stock (22,500 underlying) - Award
Stock Option (Right to Buy)
2021-05-17+11,250→ 11,250 totalExercise: $26.89Exp: 2031-05-16→ Common Stock (11,250 underlying)
Footnotes (2)
- [F1]Automatically granted pursuant to the terms of the Company's non-employee director compensation program.
- [F2]The stock option vests and becomes exercisable with respect to 1/3 of the total shares on May 17, 2022 and in equal monthly installments thereafter, subject to the Reporting Person continuing service to Issuer through each vesting date, until the shares are fully vested on May 17, 2024. Additionally, the stock options will vest in full upon the consummation of a Change in Control (as defined in the 2020 Incentive Award Plan).
Documents
Issuer
4D Molecular Therapeutics Inc.
CIK 0001650648
Entity typeother
Related Parties
1- filerCIK 0001191589
Filing Metadata
- Form type
- 4
- Filed
- May 18, 8:00 PM ET
- Accepted
- May 19, 8:33 PM ET
- Size
- 8.0 KB